Methods for Safeguarding the Air We Breathe, Part 2

The COVID-19 pandemic has thrust air quality into the spotlight, particularly in the spaces we inhabit most, such as our homes, workplaces, schools and more – and Dr. Scott A. Cohen of the Bassett Healthcare Network and infection prevention specialist Dr. Fiona Collins are back with another look at how we can go about safeguarding the air we breathe.

This time around, the two experts discussed CO2 levels, appropriate ventilation and how to get there, and other options to reduce the number of pathogens in the air and avoid exposure to large doses of the novel coronavirus and other harmful particles.

Some of those strategies include air filtration, ozone-generating purifiers, and more.

While masks and social distancing are still critical to reducing the spread of COVID-19, Collins said other recent findings in educational spaces suggest that surface disinfection isn’t overly important.

Cohen concurred, saying that “the biggest issue that we see for [coronavirus] transmission is air quality.

“This is a very efficient virus at effecting people.”

CO2 levels, then, can be used to help determine how well a space is ventilated. If the levels are high, it’s likely that ventilation is poor and the risk of transmission of harmful particles is higher.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…